XML 47 R20.htm IDEA: XBRL DOCUMENT v2.4.0.6
Segments (Tables)
9 Months Ended
Oct. 31, 2012
Segments [Abstract]  
Operating segments

The following information, in thousands, is presented for the three and nine month periods indicated below:

 

                                                 
    Three Months Ended October 31, 2012  
    Wholesale
Licensed
    Wholesale
Non-Licensed
    Retail     Other     Elimination (1)     Total  

Net sales

  $ 402,734     $ 102,616     $ 44,655     $ 6,834     $ (13,326   $ 543,513  

Cost of goods sold

    270,308       71,916       22,401       2,007       (13,326     353,306  
   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Gross profit

    132,426       30,700       22,254       4,827       —         190,207  

Selling, general and administrative (2)

    67,385       14,204       19,788       4,910       —         106,287  

Depreciation and amortization

    539       1,030       693       549       —         2,811  
   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Operating profit (loss)

  $ 64,502     $ 15,466     $ 1,773     $ (632   $ —       $ 81,109  
   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 
     
          Three Months Ended October 31, 2011  
          

Wholesale
Licensed

    Wholesale
Non-Licensed
    Retail     Elimination (1)     Total  

Net sales

          $ 374,171     $ 109,915     $ 36,880     $ (10,957   $ 510,009  

Cost of goods sold

            262,483       77,171       19,037       (10,957     347,734  
           

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Gross profit

            111,688       32,744       17,843       —         162,275  

Selling, general and administrative

            55,774       13,419       17,765       —         86,958  

Depreciation and amortization

            344       1,000       531       —         1,875  
           

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Operating profit (loss)

          $ 55,570     $ 18,325     $ (453   $ —       $ 73,442  
           

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 
   
    Nine Months Ended October 31, 2012  
    

Wholesale
Licensed

    Wholesale
Non-Licensed
    Retail     Other     Elimination (1)     Total  

Net sales

  $ 738,108     $ 198,218     $ 113,705     $ 6,834     $ (32,424   $ 1,024,441  

Cost of goods sold

    518,684       143,517       58,918       2,007       (32,424     690,702  
   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Gross profit

    219,424       54,701       54,787       4,827       —         333,739  

Selling, general and administrative ( 3 )

    149,303       33,880       54,262       4,910       —         242,355  

Depreciation and amortization

    1,542       3,007       1,866       549       —         6,964  
   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Operating profit (loss)

  $ 68,579     $ 17,814     $ (1,341   $ (632   $ —       $ 84,420  
   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 
     
          Nine Months Ended October 31, 2011  
          

Wholesale
Licensed

    Wholesale
Non-Licensed
    Retail     Elimination (1)     Total  

Net sales

          $  659,985     $ 207,433     $ 97,721     $ (28,284   $ 936,855  

Cost of goods sold

            475,029       150,291       52,518       (28,284     649,554  
           

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Gross profit

            184,956       57,142       45,203       —         287,301  

Selling, general and administrative

            122,941       32,112       49,655       —         204,708  

Depreciation and amortization

            916       2,950       1,385       —         5,251  
           

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Operating profit (loss)

          $ 61,099     $ 22,080     $ (5,837   $ —       $ 77,342  
           

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

 

(1) Represents intersegment sales to the Company’s retail operations.
(2) Includes $1.8 million of expenses and integration costs associated with the Vilebrequin acquisition which have been allocated across the segments.
(3) Includes $3.7 million of expenses and integration costs associated with the Vilebrequin acquisition which have been allocated across the segments.